Episodes featuring Moderna
93 episodes, newest first.
- Oct 4, 2026
COVID reformers confront institutional resistance and vaccine accountabilityDarkHorse PodcastOct 4, 2026 - Oct 2, 2026
Nike stumbles as AI chips and index changes reshape marketsStock MoversOct 2, 2026 - Oct 1, 2026AI deals lift Accenture and Synopsys as Moderna faces valuation testStock MoversOct 1, 2026
- Oct 1, 2026
Cockpit attack and Trump-Fed clash drive morning headlinesBloomberg Daybreak: US EditionOct 1, 2026 - Sep 30, 2026AI demand lifts Micron as defense and biotech bets falterStock MoversSep 30, 2026
- Sep 30, 2026Moderna’s rally collides with valuation risk as Robinhood expands marketsStock MoversSep 30, 2026
- Sep 30, 2026
Bongino links election stakes to COVID-era medical distrustThe Dan Bongino ShowSep 30, 2026 - Sep 30, 2026
Rate hikes meet space bets and a portfolio overhaulEquity Mates Investing PodcastSep 30, 2026 - Sep 28, 2026
AI’s race forces a choice between acceleration and controlMoonshots with Peter DiamandisSep 28, 2026 - Sep 28, 2026
AI panel shifts the risk debate from takeover to misuseMoonshots with Peter DiamandisSep 28, 2026 - Sep 28, 2026
Trade war exposes Washington’s contradictions on AI and powerRaging Moderates with Scott Galloway and Jessica TarlovSep 28, 2026 - Sep 27, 2026
AI panel rejects doom-driven pauses while confronting real risksMoonshots with Peter DiamandisSep 27, 2026 - Sep 25, 2026AI momentum lifts Meta as Gen Digital stumblesStock MoversSep 25, 2026
- Sep 25, 2026
Three stocks expose AI fervor, deal risk and biotech promiseStock MoversSep 25, 2026 - Sep 22, 2026Shopify, Moderna and On ride distinct catalystsStock MoversSep 22, 2026
- Sep 18, 2026
AI safety debate exposes limits of corporate self-regulationPivotSep 18, 2026 - Sep 17, 2026
Tarlov makes the case for disagreement without alienationRaging Moderates with Scott Galloway and Jessica TarlovSep 17, 2026 - Sep 14, 2026
AI leaders weigh safety against the cost of staying aheadMotley Fool Hidden Gems InvestingSep 14, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 12, 2026
AI loops could expand ambition, not eliminate human agencyThe a16z ShowSep 12, 2026 - Sep 3, 2026
Personalized vaccines target melanoma’s returnScience FridaySep 3, 2026 - Sep 3, 2026
AI spending strains markets as growth investors rethink riskEquity Mates Investing PodcastSep 3, 2026 - Sep 2, 2026Moderna turns tumor mutations into personalized cancer vaccinesThe a16z ShowSep 2, 2026
- Aug 30, 2026AI speculation lifts small-cap stocks as investors reassess riskWSJ's Take On the WeekAug 30, 2026